Platelet-derived endothelial cell growth factor was previously identified as the sole angiogenic activity present in platelets; it is now known to be thymidine phosphorylase (TP). Intense interest has recently centered on the angiogenic process, largely as a result of the realization that disregulated blood vessel growth plays a critical role in several disease states, including (inter alia) cancer (tumor angiogenesis), diabetic retinopathy, psoriasis, rheumatoid arthritis, and hyperproliferation of the vasa vasorum in atherosclerosis (1). Platelet-derived endothelial cell growth factor was described as a mitogenic and angiogenic factor present in platelets (2).
Intense interest has recently centered on the angiogenic process, largely as a result of the realization that disregulated blood vessel growth plays a critical role in several disease states, including (inter alia) cancer (tumor angiogenesis), diabetic retinopathy, psoriasis, rheumatoid arthritis, and hyperproliferation of the vasa vasorum in atherosclerosis (1) . Platelet-derived endothelial cell growth factor was described as a mitogenic and angiogenic factor present in platelets (2) .
Platelet-derived endothelial cell growth factor is now known to be thymidine phosphorylase (TP) (3) and the effects of TP on cellular uptake of [methyl-3H]thymidine when it is added exogenously to cells arise from its effect on the availability of thymidine in the extracellular culture medium (4) (5) (6) .
Several years prior to the isolation of the so-called plateletderived endothelial growth factor and demonstration of its angiogenic activity, TP had been identified as an enzyme whose level was significantly elevated in the plasma of cancer patients relative to that in healthy volunteers (7) and in the plasma of xenografted mice relative to that of controls (8) and expressed at a high level in tumors (9, 10) . We have found (11) that expression of TP shows a strong correlation with ovarian malignancy and ovarian tumor blood flow.
We report here that TP is angiogenic in the rat sponge model (12) and in a freeze-injured skin graft model (13) . Expression of TP strongly correlated with malignancy in breast tumors, and while expression of TP had no effect on breast carcinoma cell growth in vitro, it greatly enhanced tumor growth in vivo.
MATERIALS AND METHODS
Cell Isolation and Culture. Bovine aortic endothelial cells were isolated as described (14) and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal calf serum. Low-passage MCF-7 cells (passage 53) were a gift from Marc Lippman (Georgetown University, Washington, DC).
Antibodies to TP. Rabbit anti-TP antisera and mouse anti-TP monoclonal antibodies were raised against recombinant TP expressed in Escherichia coli (4) .
Site-Directed Mutagenesis and Protein Expression. Three site-directed mutants of TP were constructed by a two-step PCR (15) . Recombinant proteins were expressed in E. coli using the expression vector pET-14b (ams Biotechnology, Witney, U.K.) and purified by metal chelate affinity chromatography. By gel filtration, recombinant TP was dimeric with a molecular mass of 100 kDa. Concentrations of pure TP were calculated by using a molecular mass of 100 kDa.
Rat Sponge Angiogenesis Assay. Sterile circular polyether sponge discs with central cannula were implanted subcutaneously in male Wistar rats (180-200 g) after induction of neuroleptanalgesia by Hypnorm (12) . Four sponges were used in each experimental group. Protein in 50 ,ul of PBS was injected daily into the sponge. Rabbit anti-TP polyclonal antibody was purified on a protein A-Sepharose column and 25 ,tg was injected daily into the sponge. Vascularization was assessed as a function of blood flow through the implants by direct injection of 133Xe-containing saline into the sponge and its clearance was monitored over a 6-min period (12) . Sponge sections (10 ,um) were stained with hematoxylin/eosin, and the fibrovascular growth areas were measured by the axial strip sampling technique (16) that uses computer-assisted image analysis. The length/density ratio of blood vessels was calculated as described (17) .
Rat Freeze-Injured Skin Graft Assay. Isolated rat skin explants were treated with the cryoprotectant dimethyl sulfoxide [25% (vol/vol) in medium 199] and cooled to -196°C prior to rapid warming and grafting back into the skin as described (13) . TP (500 ng) was incorporated into 10 slowrelease Elvax pellets that were implanted around the perimeter of the graft.
Endothelial Cell Migration. The substance under test was placed into the bottom well of a 48-well microchemotaxis chamber (Neuroprobe, Cabin John, MD). Subconfluent bovine aortic endothelial cells were removed by exposure to trypsin and seeded (20,000 cells per well) onto a 8-,um polyvinylpyrrolidone membrane (Costar) that had been coated for 4 h with a solution of fibronectin (100 ng/ml) in PBS. After incubation for 5 h at 37°C in 5% C02/95% air, membranes were disassembled and fixed in methanol (5 min). Cells were stained with hematoxylin and three fields were counted per well at X400 with a graticule (18) .
Western Blot Analysis. Human breast tissue cytosol was prepared as described (19) . Total cytosol protein (80 ,ug) was Abbreviations: TP, thymidine phosphorylase; WT, wild type.
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Proc. Natt Acad Sci USA 92 (1995) 999 analyzed by SDS/PAGE and electroblotted onto an Immobilon-P membrane (Millipore). TP was visualized with rabbit polyclonal anti-TP antisera and 1251-labeled protein A. Immunocytochemistry. Paraffin-embedded human breast tissue sections were immunostained with anti-TP monoclonal antibody (P-GF.44c). Antibodies were visualized by the streptavidin-biotin-peroxidase technique (20) .
Overexpression of TP and Breast Carcinoma Growth. The TP gene under control of the cytomegalovirus promoter in plasmid pcDNA-1-neo (Invitrogen), was transfected into MCF-7 breast carcinoma cells and clones were isolated as described (21) . Xenografts of the MCF-7 transfectants in ovariectomized BALB/c nu/nu mice were performed as described (21) .
RESULTS
Angiogenic Activity of TP. Angiogenic activity of TP was determined by using the rat sponge model. Fig. 1A shows that recombinant human TP expressed in E. coli is angiogenic in the rat subcutaneous sponge model (12) . A statistically significant (P < 0.001) enhancement of angiogenesis was observed when daily doses of 10 or 100 pmol of TP were administered into the sponge but not with doses of 0.1 or 1 pmol (P < 0.1). Fig. 1B shows that coadministration of polyclonal rabbit anti-TP antibodies into the sponge completely blocked TPstimulated angiogenesis, whereas the antibodies had no effect on angiogenesis induced by basic fibroblast growth factor.
TP was also examined for angiogenic activity in a freezeinjured skin graft assay. We have shown (13) that revascularization of full-thickness skin autografts in rats is delayed by subjecting the graft to a sublethal freeze injury. Graft blood flow was determined by both laser Doppler flowmetry and the rate of 133Xe clearance. Fig. 1 shows that there was a statistically significant stimulation of graft blood flow with the application of 500 ng of TP per graft, when blood flow was quantitated by laser Doppler flowmetry (Fig. 1C) or by 133Xe clearance (Fig. 1D ). Fig. 2 shows TP induced vascularization compared to the control. Analysis of the sponges by measurements of the fraction of volume of fibrovascular growth and the length/density ratio of blood vessels confirmed that vascularization in the TP-treated sponges was significantly greater than in the control sponges ( Fig. 2 C and D) .
Angiogenic Activity of TP Mutants. To determine whether the enzyme activity of TP is required for angiogenic activity, active site mutants of human TP were prepared by sitedirected mutagenesis. The mutations, namely, Arg-202 -+ Glu, Lys-221 -> Glu, and Ser-217 --Ala, corresponded to residues in the E. coli TP that had been shown by x-ray crystallography to bind the nucleoside (22, 23) . The Arg and Lys mutants were enzymatically inactive [<10-4 of the wild type (WT)], whereas the Ser mutant retained 1.3% of the activity of WT/TP when assayed with thymidine. Like WT/TP, all three mutants spontaneously dimerized, as judged by gel filtration (data not shown), and we surmise that they retained an overall structure similar to that of WT/TP. Fig. 3 shows that all three TP mutants were angiogenically inactive when administered in daily doses of 10 or 500 pmol.
Chemotactic Activity of TP and Its Substrates/Products.
TP stimulated endothelial migration at 10 and 100 ng/ml in the presence of 1% fetal calf serum (Fig. 4A ) as described (2) . The three active site mutants were without activity in this assay when examined at the same concentrations. TP also stimulated migration in the absence of serum but required the presence of 0.1% bovine serum albumin and 100 nM thymidine (Fig.  4B ). In the absence of thymidine, no stimulation of migration was detected. TP in Breast Tumor Tissue. Western blot analysis showed that TP is overexpressed in breast carcinomas compared to normal breast tissue (P < 0.001) (Fig. 5 A and B) . However, immunohistochemistry revealed that the cell type expressing TP varied between tumors (Fig. 5C) . Thus, in some tumors, expression was restricted to the neoplastic element and in others it was restricted to the stromal or inflammatory component. Some staining of tumor capillary endothelium was also evident. In normal breast tissue, expression of TP was largely restricted to the inner ductal epithelial cells (Fig. SC) . vitro growth (Fig. 6B ) but all overexpressing TP clones gave statistically significantly faster growing tumors than did control cells (Fig. 6C) .
DISCUSSION
The results presented here show that recombinant TP induces vascularization in the rat sponge model and in the rat freezeinjured skin graft model. This is consistent with the reported activity of TP in the chicken chorioallantoic membrane (2) . That the enzyme activity is required for angiogenic activity was shown with three active site mutants that maintained their secondary structure, as determined by their capacity to dimerize, but had reduced TP activity. The mutants did not exhibit angiogenic activity in the rat sponge model when assayed at the (25) and to be angiogenic in vivo (26) . TP hydrolyzes thymidine to 2'-deoxy-D-ribose 1-phosphate and thymine. In turn, 2'-deoxy-D-ribose 1-phosphate is dephosphorylated to 2'-deoxy-D-ribose, which has recently been reported to be angiogenic in the chicken-chorioallantoic membrane assay (27) . However, the exact mechanism by which TP is angiogenic remains to be proven. The properties of TP described here raise the interesting possibility of therapeutic intervention in tumor growth by specific inhibition of TP. Although at present no particularly potent inhibitors of TP are known, 6-amino-5-bromouracil is among the best (28).
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